Loading clinical trials...

Safety and Efficacy of AVP-923 in PBA Patients With ALS or MS | Clinical Trials | Clareo Health

COMPLETEDPhase 3NCT00573443

Safety and Efficacy of AVP-923 in PBA Patients With ALS or MS

Objectives of the study are to evaluate the safety, tolerability, and efficacy of two different doses of AVP-923 (capsules containing either 30 mg of dextromethorphan hydrobromide and 10 mg of quinidi...

Lead sponsor: Avanir Pharmaceuticals•45 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Related studies

TERMINATEDPhase 4

Nuedexta in the Treatment of Pseudobulbar Affect in Patients With Alzheimer's Disease

NCT01832350 · Alzheimer's Disease, Pseudobulbar Affect (PBA)

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: April 12, 2017Terms

Trial snapshot

StatusCOMPLETED

PhasePHASE3

Enrollment326

Start dateDec 2007

Last updatedApr 12, 2017

Condition

Pseudobulbar Affect (PBA)

Locations shown

St. Joseph's Hospital and Medical Center

Phoenix, Arizona

Neuromuscular Research Center

Scottsdale, Arizona

South Coast Clinical Trials

Anaheim, California

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: April 12, 2017Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions